Anti-amyloid beta to tau - based immunization: Developments in immunotherapy for Alzheimer disease.

Immunotargets Ther · 2013 · PMC4051350 · PMID 24926455

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Both these findings were highly significant, with P -values of 0.0006 and 0.0071, respectively.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.